Blockade of Ca2+-activated K+ channels by galantamine can also contribute to the potentiation of catecholamine secretion from chromaffin cells

European Journal of Pharmacology

Volumn 548, Issue 1-3, 2006, Pages 45-52

  Alés, Eva ^a   Gullo, Francesca ^c   Arias, Esperanza ^a   Olivares, Román ^a   García, Antonio G ^a,b   Wanke, Enzo ^c   López, Manuela G ^a,b  

^a INSTITUTO TEÓFILO HERNANDO   (Spain)

^b HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Apamin; Catecholamines; Chromaffin cell; Galantamine; KCa2 channels

Indexed keywords

ACETYLCHOLINE; ACETYLCHOLINESTERASE; APAMIN; CALCIUM ACTIVATED POTASSIUM CHANNEL; CALCIUM ION; CATECHOLAMINE; GALANTAMINE; NEUROTRANSMITTER; NICOTINIC RECEPTOR; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM; SMALL CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CALCIUM CURRENT; CATECHOLAMINE RELEASE; CELL SUBPOPULATION; CHROMAFFIN CELL; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; MALE; MEMBRANE CONDUCTANCE; MEMBRANE POTENTIAL; NEUROPHARMACOLOGY; NEUROPHYSIOLOGY; NEUROTRANSMITTER RELEASE; NONHUMAN; PHARMACODYNAMICS; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; RAT; ACTION POTENTIAL; ADRENAL MEDULLA; ANIMAL; CATTLE; CELL CULTURE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; PHYSIOLOGY; SECRETION; SPRAGUE DAWLEY RAT;

ACETYLCHOLINE; ACTION POTENTIALS; ADRENAL MEDULLA; ANIMALS; APAMIN; CATECHOLAMINES; CATTLE; CELLS, CULTURED; CHROMAFFIN CELLS; GALANTAMINE; MALE; POTASSIUM; RATS; RATS, SPRAGUE-DAWLEY; SMALL-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS;

EID: 33748881996     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.07.032     Document Type: Article

References (36)

1. Albuquerque E.X., Pereira E.F., Alkondon M., Schrattenholz A., and Maelicke A. Nicotinic acetylcholine receptors on hippocampal neurons: distribution on the neuronal surface and modulation of receptor activity. J. Recept. Signal Transduct. Res. 17 (1997) 243-266
2. + channels in bovine chromaffin cells. Pflugers Arch. 423 (1993) 97-103
3. Behnisch T., and Reymann K.G. Inhibition of apamin-sensitive calcium dependent potassium channels facilitate the induction of long term potentiation in the CA1 region of rat hippocampus in vitro. Neurosci. Lett. 253 (1998) 91-94
4. Borges R., Sala F., and García A.G. Continuous monitoring of catecholamine release from perfused cat adrenals. J. Neurosci. Methods 16 (1986) 389-400
5. Campos-Caro A., Smillie F.I., Dominguez del Toro E., Rovira J.C., Vicente-Agullo F., Chapuli J., Juiz J.M., Sala S., Sala F., Ballesta J.J., and Criado M. Neuronal nicotinic acetylcholine receptors on bovine chromaffin cells: cloning, expression, and genomic organization of receptor subunits. J. Neurochem. 68 (1997) 488-497
6. 2+ concentration triggering exocytosis in neuroendocrine cells. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 12765-12769
7. 2+ signals and neurotransmitter release. Mol. Pharmacol. 64 (2003) 1217-1226
8. Geerts H., Guillaumat P.O., Grantham C., Bode W., Anciaux K., and Sachak S. Brain levels and acetylcholinesterase inhibition with galantamine and donepezil in rats, mice, and rabbits. Brain Res. 1033 (2005) 186-193
9. + channel blockade enhances firing and epinephrine secretion in rat chromaffin cells: the missing link to LQT2-related sudden death?. FASEB J. 17 (2003) 330-332
10. Heurteaux C., Messier C., Destrade C., and Lazdunski M. Memory processing and apamin induce immediate early gene expression in mouse brain. Mol. Brain Res. 3 (1993) 17-22
11. Ikonen S., Schmidt B., and Riekkinen P. Apamin improves spatial navigation in medial septal-lesioned mice. Eur. J. Pharmacol. 347 (1998) 13-21
12. Kondo H., Kuramoto H., and Fujita T. An immuno-electron-microscopic study of the localization of VIP-like immunoreactivity in the adrenal gland of the rat. Cell Tissue Res. 245 (1986) 531-538
13. Kurz A.F., Erkinjuntti T., Small G.W., Lilienfeld S., and Damaraju C.R. Long-term safety and cognitive effects of galantamine in the treatment of probable vascular dementia or Alzheimer's disease with cerebrovascular disease. Eur. J. Neurol. 10 (2003) 633-640
14. + channels in bovine chromaffin cells: relevance to secretion. Biochem. Pharmacol. 49 (1995) 1459-1468
15. Lingle C.J., Solaro C.R., Prakriya M., and Ding J.P. Calcium-activated potassium channels in adrenal chromaffin cells. Ion Channels 4 (1996) 261-301
16. Livett B.G. Adrenal medullary chromaffin cells in vitro. Physiol. Rev. 64 (1984) 1103-1161
17. Lovell P.V., James D.G., and McCobb D.P. Bovine versus rat adrenal chromaffin cells: big differences in BK potassium channel properties. J. Neurophysiol. 83 (2000) 3277-3286
18. Marty A., and Neher E. Potassium channels in cultured bovine adrenal chromaffin cells. J. Physiol. 367 (1985) 117-141
19. + channels, on learning and memory processes. Brain Res. 551 (1991) 322-326
20. Montiel C., Lopez M.G., Sanchez-Garcia P., Maroto R., Zapater P., and Garcia A.G. Contribution of SK and BK channels in the control of catecholamine release by electrical stimulation of the cat adrenal gland. J. Physiol. 486 (1995) 427-437
21. Moro M.A., Lopez M.G., Gandia L., Michelena P., and Garcia A.G. Separation and culture of living adrenaline-and noradrenaline-containing cells from bovine adrenal medullae. Anal. Biochem. 185 (1990) 243-248
22. Pan Y., Xu X., and Wang X. Galantamine blocks delayed rectifier, but not transient outward potassium current in rat dissociated hippocampal pyramidal neurons. Neurosci. Lett. 336 (2003) 37-40
23. + channels in cultured rat adrenal chromaffin cells. J. Physiol. Lond. 481 (1994) 555-570
24. Pirttila T., Wilcock G., Truyen L., and Damaraju C.V. Long-term efficacy and safety of galantamine in patients with mild-to-moderate Alzheimer's disease: multicenter trial. Eur. J. Neurol. 11 (2004) 734-741
25. 2+ channels in rat chromaffin cells. J. Neurophysiol. 81 (1999) 2267-2278
26. Prakriya M., and Lingle C.J. Activation of BK channels in rat chromaffin cells requires summation of Ca(2+) influx from multiple Ca(2+) channels. J. Neurophysiol. 84 (2000) 1123-1135
27. Samochocki M., Hoffle A., Fehrenbacher A., Jostock R., Ludwig J., Christner C., Radina M., Zerlin M., Ullmer C., Pereira E.F., Lubbert H., Albuquerque E.X., and Maelicke A. Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors. J. Pharmacol. Exp. Ther. 305 (2003) 1024-1036
28. Santos M.D., Alkondon M., Pereira E.F., Aracava Y., Eisenberg H.M., Maelicke A., and Albuquerque E.X. The nicotinic allosteric potentiating ligand galantamine facilitates synaptic transmission in the mammalian central nervous system. Mol. Pharmacol. 61 (2002) 1222-1234
29. Schrattenholz A., Pereira E.F., Roth U., Weber K.H., Albuquerque E.X., and Maelicke A. Agonist responses of neuronal nicotinic acetylcholine receptors are potentiated by a novel class of allosterically acting ligands. Mol. Pharmacol. 49 (1996) 1-6
30. Segura F., Brioso M.A., Gomez J.F., Machado J.D., and Borges R. Automatic analysis for amperometrical recordings of exocytosis. J. Neurosci. Methods 103 (2000) 151-156
31. Small G., Erkinjuntti T., Kurz A., and Lilienfeld S. Galantamine in the treatment of cognitive decline in patients with vascular dementia or Alzheimer's disease with cerebrovascular disease. CNS Drugs 17 (2003) 905-914
32. + channels modulate synaptic plasticity and memory encoding. J. Neurosci. 22 (2002) 10163-10171
33. Thomsen T., Kaden B., Fischer J.P., Bickel U., Barz H., Gusztony G., Cervos-Navarro J., and Kewitz H. Inhibition of acetylcholinesterase activity in human brain tissue and erythrocytes by galanthamine, physostigmine and tacrine. Eur. J. Clin. Chem. Clin. Biochem. 29 (1991) 487-492
34. + channels modulate muscarinic secretion in cat chromaffin cells. J. Physiol. 454 (1992) 213-230
35. Woodruff-Pak D., Lander C., and Geerts H. Nicotinic cholinergic modulation: galantamine as a prototype. CNS Drug Rev. 8 (2002) 375-396
36. Zang H.A., Zhang W., Jin H.W., and Wang X.L. Galantamine blocks cloned Kv2.1 but not Kv1.5 potassium channels. Mol. Brain Res. 131 (2004) 136-140